These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1078872)

  • 21. Autoreactivity between lymphocytes and thymus cells in myasthenia gravis.
    Opelz G; Keesey J; Glovsky MM; Gale RP
    Arch Neurol; 1978 Jul; 35(7):413-5. PubMed ID: 149529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The thymus gland and autoimmune diseases].
    Klug H
    Z Gesamte Inn Med; 1973 Aug; 28(15):441-50. PubMed ID: 4587798
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemical study of thymic B cells in myasthenia gravis and ulcerative colitis.
    Yokono H; Hibi T; Fujisawa T; Suzuki T; Ohbu M; Muraoka M; Tsuchiya M; Hata J
    Acta Pathol Jpn; 1993; 43(7-8):386-95. PubMed ID: 8372684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B- and T-cell activation in the thymus of patients with myasthenia gravis.
    Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
    Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The thymus in myasthenia gravis: an immunohistologic study.
    Kornstein MJ; Brooks JJ; Anderson AO; Levinson AI; Lisak RP; Zweiman B
    Adv Exp Med Biol; 1985; 186():929-36. PubMed ID: 2413737
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymic histology in myasthenia gravis.
    Malhotra V; Tatke M; Khanna SK; Gondal R
    Indian J Chest Dis Allied Sci; 1992; 34(3):117-21. PubMed ID: 1302218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study.
    Ferrio MF; Durelli L; Massazza U; Cavallo R; Poccardi G; Maggi G; Casadio C; Di Summa M; Bergamini L
    Ital J Neurol Sci; 1991 Dec; 12(6):569-73. PubMed ID: 1783535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological tolerance and myastenia. The role of thymus in growth and differentiation (author's transl)].
    Simpson JA
    Riv Patol Nerv Ment; 1974 Aug; 95(4):376-88. PubMed ID: 4470247
    [No Abstract]   [Full Text] [Related]  

  • 29. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
    Fujii N; Itoyama Y; Goto I
    Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 31. In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.
    Katzberg HD; Aziz T; Oger J
    Neurology; 2001 Feb; 56(4):572-3. PubMed ID: 11222815
    [No Abstract]   [Full Text] [Related]  

  • 32. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis.
    Zhang HL; Wu J; Ni FM; Kaji R; Matsui N; Takahama Y; Nakane S
    Neurology; 2010 Sep; 75(12):1121. PubMed ID: 20855859
    [No Abstract]   [Full Text] [Related]  

  • 33. Modeling the intrathymic pathogenesis of myasthenia gravis.
    Levinson AI
    J Neurol Sci; 2013 Oct; 333(1-2):60-7. PubMed ID: 23332143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of germinal centre (GC) cells is greatly improved by using the protease dispase to prepare cell suspensions.
    Willcox N; Schluep M; Bofill M; Newsom-Davis J
    Adv Exp Med Biol; 1985; 186():979-84. PubMed ID: 3901697
    [No Abstract]   [Full Text] [Related]  

  • 36. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.
    Thangarajh M; Masterman T; Helgeland L; Rot U; Jonsson MV; Eide GE; Pirskanen R; Hillert J; Jonsson R
    J Neuroimmunol; 2006 Sep; 178(1-2):161-6. PubMed ID: 16820216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on lymphocytes subpopulations of the thymic lymphocytes obtained from myasthenic patients (author's transl)].
    Nakata Y; Tada S; Arimori S
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):132-4. PubMed ID: 4547094
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
    Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.